Gallegos RA, Lee RS, Crawford E, Wills DN, Carr JR, Zhukov VI, Slaght KE, Huitron-Resendiz S, Criado JR, Henriksen SJ (2002) Selective lesion of ventral tegmental area neurons expressing mu-opioid receptors alters EEG power spectrum across sleep/wake cycle. Neuroscience 2002 Abstracts 276.14. Society for Neuroscience, Orlando, FL.
Summary: The ventral tegmental area (VTA) has long been implicated in motivated behaviors. Our previous study (Lee et al, J Neurosci 2001) also suggests a role for VTA GABAergic neurotransmission in REM sleep. In the current study the potential role of the VTA in modulating electroencephalogram (EEG) activation was explored by selectively deactivating mu-opioid receptor expressing cells in the VTA. Under sodium pentobarbital anesthesia, rats received either (1) a sham operation (2) a single bilateral VTA injection of NMDA (3) a saporin injection or (4) an injection of a dermorphin-saporin (DERM-SAP) conjugate (Advanced Targeting Systems, San Diego). Animals were also fitted with skull electrodes for recording the EEG. The filtered EEG was recorded continuously for 24 hours beginning 21 to 28 days after surgery. Frequency analysis of the EEG in 15-sec epochs revealed differences in the distribution of relative power in the DERM-SAP animals, compared to controls. Low frequency components (0.5-3.0 Hz and 3.0-8.0 Hz) were enhanced in dual lesioned animals during the dark phase but only during sleep. These results indicate that a selective inactivation of cells in the VTA has specific effects on arousal mechanisms in the intact animal.
Related Products: Dermorphin-SAP / MOR-SAP (Cat. #IT-12)